Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button


Home > Press > Advanced Magnetics, Inc. To Present at the 32nd Annual Deutsche Bank Health Care Conference

Advanced Magnetics, Inc. (Nasdaq: AMAG), today announced that it will participate in
the 32nd annual Deutsche Bank Health Care conference, being held in
Washington D.C. on May 2-3, 2007. Brian J.G. Pereira, MD, President and
Chief Executive Officer of Advanced Magnetics, will present an overview of
the company on Wednesday, May 2, at 8:15 am ET.

Advanced Magnetics, Inc. To Present at the 32nd Annual Deutsche Bank Health Care Conference

Cambridge, MA | Posted on April 23rd, 2007

A live webcast of this presentation will be accessible through the
Investors section of the company's website at .
The event will also be archived on the Advanced Magnetics website for a
limited period of time following the conference.


About Advanced Magnetics, Inc.
Advanced Magnetics, Inc. is a developer of superparamagnetic iron oxide
nanoparticles used in pharmaceutical products. As a leader in our field, we
are dedicated to the development and commercialization of our proprietary
nanoparticle technology for use in therapeutic iron compounds to treat
anemia, as well as novel imaging agents to aid in the diagnosis of cancer
and cardiovascular disease.

Ferumoxytol, the company's key product candidate, is being developed
for use as an intravenous (IV) iron replacement therapeutic for the
treatment of iron deficiency anemia in chronic kidney disease. The company
plans to file a New Drug Application for marketing approval of ferumoxytol
with the U.S. Food and Drug Administration during the fourth calendar
quarter of 2007.

Combidex(R), the company's other product under development, is an
investigational functional molecular imaging agent consisting of iron oxide
nanoparticles for use in conjunction with MRI to aid in the differentiation
of cancerous from normal lymph nodes. In March 2005, the company received
an approvable letter from the FDA with respect to Combidex, subject to
certain conditions.

For more information, please click here

Kristen Galfetti


Copyright © PR Newswire Association LLC.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press


Soft Probing with Optical Tweezers: Freiburg researchers have developed a method for measuring soft, structured surfaces using optical forces October 12th, 2015

Dielectric film has refractive index close to air October 12th, 2015

New Oregon approach for 'nanohoops' could energize future devices: While application is down the road, these tiny organic circular structures could be used in solar cells, light-emitting diodes and medical diagnostics October 12th, 2015

A better way to read the genome: If your genome was a library, some genes would be 'Choose Your Own Adventure' novels. October 12th, 2015


Arrowhead to Present at Upcoming Conferences October 8th, 2015

Purdue launching new quantum center during workshop October 8th, 2015

Iran Organizes Nanotechnology Educational Workshop in China October 7th, 2015

8th Int'l Iran Nano 2015 Festival Kicks Off Work October 7th, 2015

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
University Technology Transfer & Patents
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project

Car Brands
Buy website traffic